SEC Contract Filing

Filing Date: 2023-08-23

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>rtsl_ex102.htm
<DESCRIPTION>FORM OF COMMON STOCK PURCHASE WARRANT
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2023 [PPXC4Y912124VD3L1RLS]. www.edgarsuite.com -->
<HEAD>
<TITLE>Form of Common Stock Purchase Warrant</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=right style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt'><B>EXHIBIT A</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0'>NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. &nbsp;THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>FORM OF COMMON STOCK PURCHASE WARRANT</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt'><FONT style=background-color:#FFFFFF><B>RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.</B></FONT></P>
<TABLE style=border-collapse:collapse><TR><TD valign=middle style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:12pt Times New Roman;margin-top:12pt;margin-bottom:0pt'>Warrant Shares: 5,000,000</P>
</TD><TD valign=middle style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:12pt Times New Roman;margin-top:12pt;margin-bottom:0pt'>Initial Exercise Date: August 22, 2023</P>
</TD></TR>
</TABLE>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;margin-left:252pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-indent:72pt'>THIS COMMON STOCK PURCHASE WARRANT (the &#8220;<FONT style='border-bottom:1px solid #000000'>Warrant</FONT>&#8221;) certifies that, for value received, __________ or its assigns (the &#8220;<FONT style='border-bottom:1px solid #000000'>Holder</FONT>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;<FONT style='border-bottom:1px solid #000000'>Initial Exercise Date</FONT>&#8221;) and on or prior to 5:00 p.m. (New York City time) on February 22, 2029 (the &#8220;<FONT style='border-bottom:1px solid #000000'>Termination Date</FONT>&#8221;) but not thereafter, to subscribe for and purchase from <FONT style=color:#212529>Rapid Therapeutic Science Laboratories, Inc<B>.</B></FONT>, a Nevada corporation (the &#8220;<FONT style='border-bottom:1px solid #000000'>Company</FONT>&#8221;), up to 5,000,000 shares (as subject to adjustment hereunder, the &#8220;<FONT style='border-bottom:1px solid #000000'>Warrant Shares</FONT>&#8221;) of Common Stock. &nbsp;The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><KBD style='position:absolute;font:12pt Times New Roman;margin-left:0pt'><FONT style='border-bottom:1px solid #000000'>Section 1</FONT>.</KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'>Definitions</FONT>. &nbsp;In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt;color:#000000'>&#8220;<FONT style='border-bottom:1px solid #000000'>Affiliate</FONT>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt;color:#000000'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt;color:#000000'>&#8220;<FONT style='border-bottom:1px solid #000000'>Board of Directors</FONT>&#8221; means the board of directors of the Company.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt;color:#000000'>&#8220;<FONT style='border-bottom:1px solid #000000'>Business Day</FONT>&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or other day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:8pt Times New Roman;margin:0'>1</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt;color:#000000'>&#8220;<FONT style='border-bottom:1px solid #000000'>Commission</FONT>&#8221; means the United States Securities and Exchange Com